CSB-001

N/A

Report date: 2024/03/28 17:42:02

Base Information

Drug NameCSB-001
Drug Alias NameCSB-001
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionHepatocyte growth factor replacements
TargetsNot applicable
Therapy Area/IndicationsNeurotrophic KeratitisLimbal Stem Cell DeficiencyCorneal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesClaris Lifesciences Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeurotrophic KeratitisLimbal Stem Cell DeficiencyCorneal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A